Sort
326,823 grants matching “clinical trial”
Alzheimer's Disease Research Center at Columbia University
$2,406,284Scott A Small · Columbia University Health Sciences · P50 · FY2014 · AG
The ISCHEMIA-CKD Trial-CCC-Lead Application
$2,406,245Sripal Bangalore · New York University School Of Medicine · U01 · FY2017 · HL
Autoimmunity Center of Excellence Clinical Research Program
$2,406,101David Wofsy · University Of California, San Francisco · UM1 · FY2019 · AI
The District of Columbia Clinical Trials Unit (DC CTU)
$2,406,098Manya Magnus · George Washington University · UM1 · FY2022 · AI
Metro-Minnesota Community Clinical Oncology Program
$2,406,035Joseph Leach · Park Nicollet Institute · U10 · FY2012 · CA
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
$2,405,885James R Cerhan · Mayo Clinic Rochester · U01 · FY2015 · CA
Unit on Neuroscience and Novel Therapeutics
$2,405,790Melissa Brotman · National Institute Of Mental Health · ZIA · FY2022 · MH
Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms
$2,405,695Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
UCLA SPORE IN LUNG CANCER
$2,405,646University Of California Los Angeles · P50 · FY2004 · CA
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial
$2,405,613Sundeep Khosla · Mayo Clinic Rochester · R01 · FY2022 · AG
Scientific innovation for personalized severe asthma management
$2,405,551Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2023 · HL
Case AIDS Clinical Trials Unit
$2,405,283Michael Marcel Lederman · Case Western Reserve University · U01 · FY2007 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$2,405,177Michael David Hughes · Harvard School Of Public Health · UM1 · FY2021 · AI
EPIDEMIOLOGY OF DEMENTIA IN AN URBAN COMMUNITY
$2,405,115Columbia University Health Sciences · P01 · FY2003 · AG
"REAL Answers" (Registry Expansion Analyses to Learn)
$2,405,068Jeffrey Avins Glassberg · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · HL
Novel Treatment for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
$2,405,066Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Novel Treatment for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
$2,405,066Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Coordinating Center for the Undiagnosed Diseases Network
$2,404,964Isaac S. Kohane · Harvard Medical School · U01 · FY2017 · HG
System Biological Analyses of Innate and Adaptive Responses to Vaccination
$2,404,885Bali Pulendran · Emory University · U19 · FY2020 · AI
THE THERAPY OF AML
$2,404,845Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder
$2,404,826Helen B. Tager-Flusberg · Boston University (Charles River Campus) · P50 · FY2022 · DC
Predicting and Optimizing Language Outcomes in Minimally Verbal Children with Autism Spectrum Disorder
$2,404,704Helen B. Tager-Flusberg · Boston University (Charles River Campus) · P50 · FY2021 · DC
Bronchiectasis and chronic airway infection
$2,404,445Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
PHRU-Setshaba Clinical Trials Unit
$2,404,119Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
CURE CTU
$2,404,040Stephen A Spector · University Of California, San Diego · UM1 · FY2025 · AI